We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Pituitary Stalk Interruption Syndrome: Analysis of Response to Growth Hormone Therapy

    Objective

    To analyse the clinical and radiological characteristics of pituitary stalk interruption syndrome (PSIS).

    Methods

    A retrospective analysis...

    Raghuraman Ravichandran, Uma K. Saikia, ... Abhamoni Baro in Indian Pediatrics
    Article 20 February 2024
  2. Effects of Hormone Replacement Therapy on Women's Lung Health and Disease

    This review provides an overview of menopausal hormone therapy and pulmonary disease risk, with a focus on the effect of hormone replacement therapy...

    Efrat Eliyahu, Michael G. Katz, ... Bezalel Arkush in Pulmonary Therapy
    Article Open access 10 October 2023
  3. Long-term breast cancer incidence trends by mammography, obesity, and menopausal hormone therapy

    Purpose

    Over the past half century, the annual age-adjusted breast cancer incidence in the USA has fluctuated, potentially influenced by changes in...

    Rowan T. Chlebowski, Aaron K. Aragaki in Breast Cancer Research and Treatment
    Article 20 September 2023
  4. Antiosteoporosis therapy after discontinuation of menopausal hormone therapy: a systematic review

    Objective

    Menopausal hormone therapy (MHT) has consistently shown a bone protective effect by reducing the risk of vertebral, non-vertebral, and hip...

    Panagiotis Anagnostis, Efstathios Divaris, ... Dimitrios G. Goulis in Hormones
    Article Open access 18 January 2024
  5. Impact of medical therapy for hormone-secreting Pituitary tumors on bone

    Purpose

    Bone health is often impaired in patients with hormone-secreting pituitary tumors. Since medical therapy is central to their care,...

    Pamela U. Freda in Pituitary
    Article 05 July 2024
  6. Growth hormone therapy response in children with short stature

    Background

    Short stature is one of the main causes of children referral to pediatric endocrinologists. Common etiologies include idiopathic growth...

    Amira Ahmed Gad, Radwa Shamma, ... Mona Mamdouh Hassan in Egyptian Pediatric Association Gazette
    Article Open access 05 June 2023
  7. Pelvic Floor Dysfunction in Transgender Men on Gender-affirming Hormone Therapy: A Descriptive Cross-sectional Study

    Introduction and Hypothesis

    The objective of this research is to explore the effects of hormone therapy using testosterone on pelvic floor dysfunction...

    Lyvia Maria Bezerra da Silva, Silvana Neves Dias Freire, ... Leila Barbosa in International Urogynecology Journal
    Article 25 April 2024
  8. Menopausal Hormone Therapy in Older Women: Examining the Current Balance of Evidence

    Menopause occurs in all women. During the menopause transition, 80% of women experience vasomotor symptoms that can last an average of 7–10 years or...

    Paru S. David, Talia Sobel, ... Juliana M. Kling in Drugs & Aging
    Article 21 June 2023
  9. Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy

    Purpose

    This review focuses on post-operative thyroid hormone replacement and thyrotropin suppression therapy in patients with differentiated thyroid...

    Benjamin J. Gigliotti, Sina Jasim in Endocrine
    Article 12 October 2023
  10. Postmenopausal Osteoporosis: Menopause Hormone Therapy and Selective Estrogen Receptor Modulators

    Introduction

    Osteoporosis is a debilitating silent disease with a huge socio-economic impact. Prevention strategies and early detection of...

    Jyotsna Rani, Swati Swati, ... Akanshi Madan in Indian Journal of Orthopaedics
    Article 07 December 2023
  11. The effect of hormone therapy on physiological uptake of the endometrium on [18F]F-FDG PET in postmenopausal women

    Objective

    The effects of hormonal therapy, estrogen-based hormone replacement therapy (HRT), and anti-tumor hormone therapy, such as tamoxifen, on the...

    Ryusuke Nakamoto, Masahiro Yakami, ... Yuji Nakamoto in Annals of Nuclear Medicine
    Article 18 May 2024
  12. Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men

    Purpose

    While it is common for menstrual cycles to cease within the initial 6 months of treatment, there are instances where some transgender men may...

    E. D. da Silva, P. M. Spritzer, T. M. Fighera in Journal of Endocrinological Investigation
    Article 01 February 2024
  13. Prevalence of menopausal symptoms and attitudes towards menopausal hormone therapy in women aged 40–60 years: a cross-sectional study

    Background

    Menopause is a specific physical and psychological transition period for women, during which they experience a series of menopausal...

    Jie Lu, Kangfen Li, ... Lingling **e in BMC Women's Health
    Article Open access 04 September 2023
  14. Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials

    Summary

    In a combined analysis of 25,389 postmenopausal women aged 50–79 years, enrolled in the two Women’s Health Initiative hormone therapy trials,...

    Mattias Lorentzon, Helena Johansson, ... John A. Kanis in Osteoporosis International
    Article Open access 14 July 2022
  15. Genomic Testing to Guide Local Therapy Decisions in Hormone Receptor-Positive Breast Cancer

    Purpose of Review

    To explore how genomic testing has changed local therapy decision-making, specifically surgical timing and opportunities for...

    Kate Lloyd, Olga Kantor in Current Breast Cancer Reports
    Article 07 March 2024
  16. The outcomes of growth hormone therapy in the obstructive sleep apnea parameters of Prader–Willi syndrome patients: a systematic review

    Purpose

    Prader–Willi syndrome is a serious genetic condition, capable of causing endocrinological imbalance, which has as one of its main treatments...

    Gabriel Rossi Francisco, Júlia Leão Batista Simões, ... Margarete Dulce Bagatini in European Archives of Oto-Rhino-Laryngology
    Article 22 December 2023
  17. Metastatic Hormone–Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy

    Treatment for metastatic hormone–sensitive prostate cancer has undergone significant evolution in recent years, leading to substantial improvements...

    Anthony V. Serritella, Maha Hussain in Current Treatment Options in Oncology
    Article 04 January 2024
  18. Vaginal Hormone Therapy for Conditions of the Lower Urinary Tract

    Purpose of Review

    Up to half of postmenopausal women experience genitourinary symptoms secondary to hormone deficiency, and there is little consensus...

    Amy Nemirovsky, Natalia Arias Villela, ... Rena D. Malik in Current Urology Reports
    Article 01 December 2022
  19. Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review

    Introduction

    Metastatic hormone-sensitive prostate cancer (mHSPC) displays both simultaneous and sequential patterns of metastasis, emphasizing...

    Stephan Brönimann, Nirmish Singla, ... Shahrokh F Shariat in memo - Magazine of European Medical Oncology
    Article Open access 16 January 2024
  20. A Non-Inferiority Study on Endometrial Preparation Prior to FET-Letrozole Versus Hormone Replacement Therapy

    Background

    To compare the efficacy of letrozole-stimulated cycles to the more conventional artificial programmed cycles, in endometrial preparation...

    Asha R. Rao, R. Aiswarya, ... Damodar Rao in The Journal of Obstetrics and Gynecology of India
    Article 06 February 2024
Did you find what you were looking for? Share feedback.